Similar articles

• [Cholesteryl ester transfer protein (CETP)].

  Kinoshita M. Kinoshita M. Nihon Rinsho. 2004 Dec;62 Suppl 12:92-4. Nihon Rinsho. 2004. PMID: 15658271 Review. Japanese. No abstract available.
• Cholesteryl ester transfer protein and coronary artery disease: an observation with therapeutic implications.

  Wolfe ML, Rader DJ. Wolfe ML, et al. Circulation. 2004 Sep 14;110(11):1338-40. doi: 10.1161/01.CIR.0000143047.52724.BB. Circulation. 2004. PMID: 15364817 No abstract available.
• Apolipoprotein B and non-high-density lipoprotein cholesterol are better risk markers for coronary artery disease than low-density lipoprotein cholesterol in hypertriglyceridemic metabolic syndrome patients.

  Boumaiza I, Omezzine A, Rejeb J, Rebhi L, Kalboussi N, Ben Rejeb N, Nabli N, Ben Abdelaziz A, Boughazala E, Bouslama A. Boumaiza I, et al. Metab Syndr Relat Disord. 2010 Dec;8(6):515-22. doi: 10.1089/met.2010.0006. Epub 2010 Aug 17. Metab Syndr Relat Disord. 2010. PMID: 20715933 Clinical Trial.
• [Clinical significance of plasma total cholesterol, free cholesterol and esterified cholesterol levels].

  Taki M, Teramoto T. Taki M, et al. Nihon Rinsho. 2004 Dec;62 Suppl 12:10-3. Nihon Rinsho. 2004. PMID: 15658250 Review. Japanese. No abstract available.
• [Low concentrations of high-density lipoproteins (HDL) in plasma and coronary artery disease].

  Pérez-Méndez O, Luc G, Posadas-Romero C. Pérez-Méndez O, et al. Arch Inst Cardiol Mex. 2000 May-Jun;70(3):312-21. Arch Inst Cardiol Mex. 2000. PMID: 10959461 Review. Spanish. No abstract available.